Hi RLGPhD,
It wasn’t factual (your post). The CLARITY 2.0 and REMAP-CAP International COVID-19 trials are covered $.
FSGS next step in Ph3 & correct we are waiting on news for that to hear how that will be covered in a larger & lengthier trial. It was always the plan for DKD to be out-licenced.
Why my comment, & it wasn’t intended to be rude, your posts are usually more in-depth in explanation, but that one wasn’t. That’s all.
Ann: Half Year Report and Update, page-77
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
0.015(2.83%) |
Mkt cap ! $299.6M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 54.5¢ | 52.0¢ | $905.8K | 1.698M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8606 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 72714 | 5 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |